Semnur Pharmaceuticals SMNR
OTC SMNR
$0.37 -0.01 (-2.63%)
At close: Oct 23, 2026 · 4:00 PM EDT

Semnur Pharmaceuticals (SMNR) Total Liabilities (2022 - 2026)

Updated

Semnur Pharmaceuticals (SMNR) posted Total Liabilities of $31.62 million for Q2 2026, down 29.8% from $45.01 million a year earlier but up 15.8% from the prior quarter.

Analysis

Semnur Pharmaceuticals (SMNR) Total Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, Semnur Pharmaceuticals' Total Liabilities came in at $22.1 million, down 55.3% from FY2024.

  • Annual Total Liabilities has declined for three consecutive years, with a three-year compound annual growth rate of -37.3% (FY2022 to FY2025).
  • In prior years, Semnur Pharmaceuticals' Total Liabilities was $49.47 million in FY2024 (-44.3%), $88.78 million in FY2023 (-0.9%) and $89.55 million in FY2022.
  • Quarterly Total Liabilities has run from a low of $428,225 in Q1 2022 to a high of $98.08 million in Q3 2023 over five years.
  • On a year-over-year basis, Total Liabilities has declined in each of the last 11 quarters, with an average decline of 48.6% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was Q3 2023, with growth of 11.9%; the weakest was Q3 2025, with a decline of 69.8%.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $27.3 million (Q1 2026), $22.1 million (Q4 2025) and $15.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 115.90 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 141.05 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 37.53 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 115.64 Bn
10 Semnur Pharmaceuticals 85.18 Mn 84.92 Mn - 31.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.62 Mn
Mar 31, 2026 27.30 Mn
Dec 31, 2025 22.10 Mn
Sep 30, 2025 15.37 Mn
Jun 30, 2025 45.01 Mn
Mar 31, 2025 52.60 Mn
Dec 31, 2024 49.47 Mn
Sep 30, 2024 50.93 Mn
Jun 30, 2024 92.83 Mn
Mar 31, 2024 90.95 Mn
Dec 31, 2023 88.78 Mn
Sep 30, 2023 98.08 Mn
Jun 30, 2023 94.78 Mn
Mar 31, 2023 92.15 Mn
Dec 31, 2022 89.55 Mn
Sep 30, 2022 87.62 Mn
Jun 30, 2022 87.20 Mn
Mar 31, 2022 428,225.00
API Access

Semnur Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=SMNR&period=max&api_key=YOUR_API_KEY